| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.186 | 2.381 | 0 | 9.729 | 39.481 | 5.185 | 16.343 | 52.250 | 56.811 | 10.665 |
| Total Income - EUR | 16.210 | 2.381 | 0 | 9.816 | 39.481 | 5.185 | 16.343 | 52.251 | 58.973 | 10.665 |
| Total Expenses - EUR | 9.295 | 2.523 | 245 | 19.321 | 23.492 | 4.056 | 2.314 | 4.220 | 28.353 | 9.883 |
| Gross Profit/Loss - EUR | 6.915 | -142 | -245 | -9.505 | 15.989 | 1.130 | 14.029 | 48.031 | 30.620 | 782 |
| Net Profit/Loss - EUR | 6.429 | -189 | -245 | -9.797 | 14.804 | 1.025 | 13.708 | 46.699 | 30.118 | 485 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Gemini Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.582 | 1.316 | 1.049 | 790 | 539 | 373 | 259 | 145 | 783 | 599 |
| Current Assets | 6.483 | 5.573 | 5.478 | 984 | 14.000 | 15.800 | 29.099 | 76.172 | 107.108 | 103.130 |
| Inventories | 1.320 | 975 | 958 | 941 | 923 | 919 | 899 | 7.099 | 0 | 0 |
| Receivables | 1.462 | 4.553 | 4.476 | 0 | 11.379 | 14.448 | 28.199 | 67.583 | 106.005 | 99.010 |
| Cash | 3.701 | 45 | 44 | 43 | 1.698 | 433 | 1 | 1.489 | 1.102 | 4.120 |
| Shareholders Funds | 6.197 | 5.945 | 5.600 | -4.300 | 10.588 | 11.412 | 24.867 | 71.669 | 101.570 | 101.487 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.867 | 944 | 928 | 6.074 | 3.951 | 4.328 | 4.490 | 4.648 | 6.321 | 2.242 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 433 | 1 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Gemini Med S.r.l.